No Data
MediPharm Labs Brief: Net Revenue $9.8 Million in Q3 2024, a 15% Increase as Compared to Q3 2023; Cites Strong Growth in International GMP Medical Markets
MediPharm Labs Corp. Brief: Announcing Departure of President and Co-Founder Keith Strachan
MediPharm Labs "Materially" Debt-Free After $2.1 Million Debt Payment
MediPharm Labs Corp. (MEDIF) Q2 2024 Earnings Call Transcript Summary
Press Release: MediPharm Labs Reports Second Quarter Results Closing in on Positive Adjusted EBITDA(1) as Gross Profit Continues to Improve
Press Release: MediPharm Labs Announces Voting Results From the 2024 Annual Meeting of Shareholders
No Data